Status:
COMPLETED
Eye Movement Desensitization and Reprocessing on Autoimmune Thyroiditis in Adults
Lead Sponsor:
University of Bucharest
Conditions:
Hashimoto
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate whether Eye Movement Desensitization and Reprocessing (EMDR) is effective in decreasing the level of autoantibodies of patients with autoimmune thyroiditis. Th...
Detailed Description
Hashimoto thyroiditis is an autoimmune disease that leads to chronic inflammation of the thyroid gland. This is considered the most common autoimmune disorder, and the most common endocrine disorder. ...
Eligibility Criteria
Inclusion
- aged 18-55 years;
- confirmed autoimmune thyroiditis diagnosis
- at least one biological marker Anti-thyroid peroxidase (anti-TPO) antibodies or thyroglobulin antibodies (TgAb) exceeds the reference range
Exclusion
- the presence of psychotic symptoms
- currently receiving another form of psychological treatment;
- under psychotropic medication;
- neurodevelopmental disorders (intellectual disability, communication disorders, autism spectrum disorders, ADHD);
- neurocognitive disorders;
- substance abuse;
- serious legal or health issues that would prevent from regularly attending
- patients with autoimmune thyroiditis with biological markers within the reference range
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 23 2021
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT04472988
Start Date
January 1 2020
End Date
March 23 2021
Last Update
April 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Bucharest
Bucharest, Romania